Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 26.235 USD 0.83%
Market Cap: 1.2B USD

Relative Value

The Relative Value of one CAPR stock under the Base Case scenario is hidden USD. Compared to the current market price of 26.235 USD, Capricor Therapeutics Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CAPR Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
31
vs Industry
27
Median 3Y
24.9
Median 5Y
32.1
Industry
7.9
Forward
883.7
vs History
vs Industry
Median 3Y
-5.2
Median 5Y
-5.3
Industry
23.7
Forward
-11.9
vs History
vs Industry
8
Median 3Y
-6
Median 5Y
-6.2
Industry
22
vs History
vs Industry
3
Median 3Y
-5.5
Median 5Y
-5.7
Industry
23.8
vs History
9
vs Industry
10
Median 3Y
8.3
Median 5Y
4.6
Industry
3.3
vs History
30
vs Industry
24
Median 3Y
16.8
Median 5Y
23.9
Industry
8.3
Forward
811.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-4.5
Industry
6.4
Forward
-10.4
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-4.3
Industry
7
Forward
-10.4
vs History
vs Industry
11
Median 3Y
-4.3
Median 5Y
-4.2
Industry
8.3
vs History
vs Industry
5
Median 3Y
-4
Median 5Y
-3.9
Industry
6.5
vs History
23
vs Industry
1
Median 3Y
34.4
Median 5Y
21.1
Industry
5.7

Multiples Across Competitors

CAPR Competitors Multiples
Capricor Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Capricor Therapeutics Inc
NASDAQ:CAPR
1.2B USD 107.8 -14.6 -13 -12.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 809 907.8 -160 693.5 -195 133.1 -192 906.4
US
Abbvie Inc
NYSE:ABBV
400.7B USD 6.7 170.6 16.5 23.4
US
Amgen Inc
NASDAQ:AMGN
172.3B USD 4.8 24.6 17.8 17.8
US
Gilead Sciences Inc
NASDAQ:GILD
149.8B USD 5.1 18.5 12.4 12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.6B USD 9.8 31.1 22.9 23.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 083.7 -531.7 -579 -563.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD 5.6 17.3 16.5 18.7
AU
CSL Ltd
ASX:CSL
86.8B AUD 3.7 19.2 12.9 16.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52B USD 16.2 1 194.7 156.9 190.3
NL
argenx SE
XBRU:ARGX
42.9B EUR 14 32.9 56.5 58.1
P/E Multiple
Earnings Growth PEG
US
Capricor Therapeutics Inc
NASDAQ:CAPR
Average P/E: 188.6
Negative Multiple: -14.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 693.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
170.6
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.6
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.5
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.1
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
9%
1.9
AU
CSL Ltd
ASX:CSL
19.2
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 194.7
N/A N/A
NL
argenx SE
XBRU:ARGX
32.9
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Capricor Therapeutics Inc
NASDAQ:CAPR
Average EV/EBITDA: 39
Negative Multiple: -13
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 133.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.8
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.5
11%
1.5
AU
CSL Ltd
ASX:CSL
12.9
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
156.9
N/A N/A
NL
argenx SE
XBRU:ARGX
56.5
839%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Capricor Therapeutics Inc
NASDAQ:CAPR
Average EV/EBIT: 45.1
Negative Multiple: -12.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 906.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.8
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.7
13%
1.4
AU
CSL Ltd
ASX:CSL
16.1
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
190.3
N/A N/A
NL
argenx SE
XBRU:ARGX
58.1
N/A N/A